Eudamed Workshop Overview – May 2025

On 21 May 2025, the first free EUDAMED workshop was held in Stuttgart, providing practical guidance to economic operators, notified bodies, competent authorities, and other stakeholders. The focus was to prepare for the mandatory use of Eudamed Database under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). 

The workshop combined regulatory insights with hands-on guidance, focusing on how to use key modules of the EUDAMED system: Actors, UDI/Devices, Certificates, Notified Bodies, and Market Surveillance.

Below is a breakdown of the key aspects discussed during this Workshop.

Transitional Timelines and Functional Module Rollout 

The workshop highlighted the importance of Regulation (EU) 2024/1860, which particularly amended Articles 34 and 123 of the MDR. These changes enable the gradual rollout of Eudamed modules, allowing them to be declared functional individually or in groups, rather than requiring all six modules to be ready simultaneously. 

In addition, the regulation aligned the transitional period for each module (with some exceptions to device registration and certificates that will be described further below) to six months from the publication of the official notice declaring the modules functional. 

Current Status of Eudamed 

As of May 2025, the first four EUDAMED modules: Actors, UDI/Devices, Certificates, and Market Surveillance, have been finalised and are currently undergoing an audit. A final audit report and the official notice of functionality are expected by late summer 2025, triggering the six-month transition period before they become mandatory for use. These four modules are planned to become mandatory by Q1 of 2026. 

The Vigilance module is expected to follow in Q3 2026, while the timeline for the Clinical Investigations module remains unconfirmed.  

Notably, only the first four modules are available for voluntary use before they become mandatory. Vigilance and Market Surveillance can only be used once their mandatory use begins. 

EUDAMED System Overview 

Eudamed consists of a restricted portal for registered actors and a public website that will provide transparency on devices placed on the EU market, vigilance data, certificates, and clinical investigations. 

The platform is built on three environments: 

  • Eudamed Production – Live environment for real data 
  • Eudamed Playground – Testing environment with dummy data 
  • Eudamed Training – Public environment for training before modules become mandatory 

Data can be submitted through manual entry, bulk XML upload, or machine-to-machine (M2M) communication. The user interface will also support multilingual use in the future. 

UDI/Device Module: Key Timelines 

  • MDR Devices: MDR devices placed on the EU market after the module mandatory date must be registered before market placement. However, if an MDR device was already on the market prior to the mandatory use date and continues to be marketed, manufacturers have 12 months from publication of the notice to register it. 
  • Legacy Devices: If a legacy device was already on the market prior to the module’s mandatory use date and continues to be marketed, manufacturers have 12 months from publication of the notice to register it. 
  • Legacy Devices Transitioned to MDR Devices: If a legacy device has been made MDR-compliant using the same UDI-DI, and the MDR is already registered, the legacy version does not need to be registered, unless a vigilance event involves only the legacy version. 
  • Obsolete Devices: Devices (Legacy or MDR) no longer placed on the market do not need to be registered unless there is a vigilance incident. 

Certificates Module: Key Timelines 

  • Certificates issued after the module’s mandatory date must be registered in Eudamed. 
  • For Certificates issued before the module’s mandatory date, Notified Bodies must register information related to these certificates within 18 months of the notice publication. 
  • If a certificate is issued before the mandatory use, but there are certificate updates or decisions issued after the mandatory use, these updates or decisions must be registered in the module. 

Important: For certain high-risk devices, if a manufacturer registers a device but the Notified Body has not yet uploaded the certificate, the device will appear as “submitted” (not visible to the public, only to competent authorities). It is crucial that manufacturers coordinate with Notified Bodies before registration. 

Data Management on the UDI/Device Module 

  • Draft status: Entries can be deleted. 
  • Submitted/Registered status: Entries cannot be deleted; updates require the creation of a new version. 
  • If MDR requirements change, EUDAMED will allow appropriate updates to existing entries. 

Market Surveillance and Certificates Modules: Key Aspects 

  • The Market Surveillance and Certificates Modules are dedicated to Competent Authorities, Designated Authorities, the European Commission and notified bodies.  
  • The Certificates module only applies to MDR-compliant devices, not legacy ones. 
  • Most market surveillance reports provided on Eudamed will not be publicly available, including: 
  • Annual and final inspection reports  
  • Incident reports involving unacceptable risks 
  • Corrective actions requested by Competent Authorities 

However, a four-year summary report, which reviews market surveillance activities across member states, will be made available to the public. 

Additional Information 

  • The Actor registration process for non-EU System and Procedure Pack (SPP) producers will be managed by the Competent Authority of the country where the product is first placed on the market. 
  • Currently, SPPs are not subject to vigilance obligations in Eudamed. 
  • Contact and Support: For technical or regulatory queries regarding Eudamed, contact: SANTE-EUDAMED-SUPPORT@ec.europa.eu

How Specculo Can Support You with Eudamed

The rollout of Eudamed is entering a critical phase, and staying ahead of its evolving requirements is essential for smooth EU market access. At Specculo, we offer hands-on support to ensure you’re prepared, technically and strategically, for each phase of the transition.

We assist manufacturers, authorised representatives, and importers with:

  • Actor registration and liaison with Competent Authorities
  • UDI/Device module submissions, including guidance on UDI structure, data entry, and registration
  • Coordination with Notified Bodies to ensure timely certificate uploads and alignment between parties
  • Interpretation of transition timelines, obligations for legacy vs MDR devices, and certificate rules
  • Internal process alignment, including SOP updates, roles/responsibilities, and system integration planning
  • Ongoing support for data updates, regulatory change tracking, and readiness for future module launches (Vigilance and Clinical Investigations)

Whether you’re preparing for your first upload or need ongoing EUDAMED compliance support, our team provides regulatory clarity and practical assistance, so you stay compliant and ready as each module becomes mandatory.

See our Eudamed Registration service here.